← FDA DRUG APPROVALS
FDA ANDA · ANDA090721
FALMINA
levonorgestrel and ethinyl estradiol
Sponsor: NOVAST LABS LTD
APPLICATION
ANDA090721
TYPE
ANDA
ORIGINAL APPROVAL
2012-03-28
LATEST ACTION
2022-04-29
ROUTE
ORAL-28
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
FALMINAPrescription
ETHINYL ESTRADIOL 0.02MG, LEVONORGESTREL 0.1MG · TABLET · ORAL-28
Approval history
2022-04-29Labeling · Supplement 7 · standardAP
2017-08-09Labeling · Supplement 2 · standardAP
2012-03-28OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.